Vanguard TKA With KneeAlign 2 and Without KneeAlign 2

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 24, 2016

Primary Completion Date

October 3, 2018

Study Completion Date

October 26, 2018

Conditions
Osteoarthritis, Knee
Interventions
DEVICE

KneeAlign 2

Patients suffering non-severe varus deformity Osteoarthritis will be enrolled and randomly assigned into one of two treatment groups. Patients in investigational group will be treated with total knee arthroplasty and the accelerometer-based navigational device. Patients in control group will be treated with total knee arthroplasty with conventional instrumentation.

Trial Locations (1)

558-0022

Osaka City University, Osaka

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT02695329 - Vanguard TKA With KneeAlign 2 and Without KneeAlign 2 | Biotech Hunter | Biotech Hunter